Liang-Yu Lin (L-Y Lin)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Scientific reports

Journal of endocrinological investigation

PloS one

Science translational medicine

Taipei Veterans General Hospital

National Yang-Ming University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Taipei Veterans General Hospital

Taiwan

Attending physician :: Div. Endocrinol & Metab

Education History

National Yang-Ming University Sep 01 2009 - Jan 10 2015

Taiwan

PHD :: Institute of Pharmacology

Publications

Liang-Yu Lin, Ting-Ting Chang, Hsin-Bang Leu, Chin-Chou Huang, Tao-Cheng Wu, Ruey-Hsin Chou, Po-Hsun Huang, Wei-Hsian Yin, Wei-Kung Tseng, Yen-Wen Wu, Tsung-Hsien Lin, Hung-I Yeh, Kuan-Cheng Chang, Ji-Hung Wang, Chau-Chung Wu, Jaw-Wen Chen
Novel prognostic impact and cell specific role of endocan in patients with coronary artery disease. Clinical research in cardiology : official journal of the German Cardiac Society (2024)
Ting-Ting Chang, You-Zhen Li, Hsiao-Wei Mo, Ching Chen, Liang-Yu Lin, Chia-Chi Chang, Jaw-Wen Chen
Inhibition of CCL7 improves endothelial dysfunction and vasculopathy in mouse models of diabetes mellitus. Science translational medicine 16 (763) (2024)
Li-Hsin Chang, Chia-Huei Chu, Chin-Chou Huang, Liang-Yu Lin
Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus. Therapeutic advances in endocrinology and metabolism 14 (2023)
Tsung-Hui Wu, Li-Hsin Chang, Chia-Huei Chu, Chii-Min Hwa, Harn-Shen Chen, Liang-Yu Lin
Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus. PloS one 17 (4) (2022)
L-H Chang, C-M Hwu, C-H Chu, Y-C Lin, C-C Huang, J-Y You, H-S Chen, Liang-Yu Lin
The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus. Journal of endocrinological investigation 44 (12) (2021)
Chin-Sung Kuo, Jia-Shiong Chen, Liang-Yu Lin, Geert W Schmid-Schönbein, Shu Chien, Po-Hsun Huang, Jaw-Wen Chen, Shing-Jong Lin
Inhibition of Serine Protease Activity Protects Against High Fat Diet-Induced Inflammation and Insulin Resistance. Scientific reports 10 (1) (2020)

Liang-Yu Lin.css-eqlu8i{font-size:small;padding-left:4px;} (L-Y Lin)

Publication Activity (10 Years)

Top Topics

Top Venues

Liang-Yu Lin (L-Y Lin)